Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Harvard Business School
Moodys
Covington
Fish and Richardson
Julphar
Daiichi Sankyo
Deloitte
Argus Health

Generated: April 20, 2018

DrugPatentWatch Database Preview

BUTICAPS Drug Profile

« Back to Dashboard

When do Buticaps patents expire, and what generic alternatives are available?

Buticaps is a drug marketed by Medpointe Pharm Hlc and is included in one NDA.

The generic ingredient in BUTICAPS is butabarbital sodium. There are nine drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the butabarbital sodium profile page.
Drug patent expirations by year for BUTICAPS
Synonyms for BUTICAPS
125-40-6
143-81-7
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-methylpropyl)-, sodium salt
2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(2-methylpropyl)-, sodium salt (9CI)
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-
2,6(1H,3H,5H)-Pyrimidinetrione, 5-ethyl-5-(1-methylpropyl)-, monosodium salt
5-(butan-2-yl)-5-ethyl-1,3-diazinane-2,4,6-trione
5-(butan-2-yl)-5-ethyl-4,6-dihydroxy-2,5-dihydropyrimidin-2-one
5-(butan-2-yl)-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
5-butan-2-yl-5-ethyl-1,3-diazinane-2,4,6-trione
5-Ethyl-5-(1-methylpropyl)-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Ethyl-5-(1-methylpropyl)barbiturate
5-Ethyl-5-(1-methylpropyl)barbituric acid
5-Ethyl-5-(1-methylpropyl)barbituric acid sodium salt
5-Ethyl-5-(1-methylpropyl)barbituric acid, sodium salt
5-ethyl-5-(1-methylpropyl)pyrimidine-2,4,6(1H,3H,5H)-trione
5-ethyl-5-sec-butyl-barbituric acid
5-ethyl-5-sec-butyl-hexahydropyrimidine-2,4,6-trione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione
5-Sec-butyl-5-ethyl-2,4,6(1H,3H,5H)-pyrimidinetrione #
5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID
5-SEC-BUTYL-5-ETHYL-BARBITURIC ACID, NA SALT
5-sec-Butyl-5-ethylbarbituric acid
5-sec-Butyl-5-ethylbarbituric acid sodium salt
5-sec-Butyl-5-ethylbarbituric acid, sodium salt
5-sec-Butyl-5-ethylmalonyl urea
5-sec-butyl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
97164-73-3
AC-16078
AC1L1DRT
AC1Q1VYO
AKOS015962208
AN-22964
API0004766
Asturidon
Barbitab
Barbituric acid, 5-ethyl-5-isobutyl-
Barbituric acid, 5-ethyl-5-isobutyl-, sodium salt
Barbituric acid, 5-sec-butyl-5-ethyl-
Barbituric acid, 5-sec-butyl-5-ethyl-, sodium salt
BRN 0199127
BRN 0199734
Bubartal
Bubartal TT
Butabarb
Butabarb (TN)
butabarbital
Butabarbital (USP)
Butabarbital (VAN)
Butabarbital [USAN]
Butabarbital [USP]
Butabarbital |||5-sec-Butyl-5-ethylbarbituric acid
BUTABARBITAL SODIUM
Butabarbital sodium (USP)
Butabarbital sodium [USAN]
Butabarbital sodium [USP]
Butabarbital solution, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material
Butabarbitone
Butabarbitone sodium
Butabarpal sodium
Butak
Butalan
Butasaron
Butased
Butatab
Butatal
Butatal sodium
Butazem
Butibel
Butisol
Butisol (TN)
Butisol sodium
Butrate
C07827
C10H15N2NaO3
Cambrised
Carrbutabarb
CHEBI:3228
CHEBI:3229
CHEMBL1200982
CHEMBL449
Ciprial
component of Butibel
CS-7224
D00699
D03180
D0A4JK
DB00237
DTXSID2022709
EINECS 204-738-6
EINECS 205-611-8
Expansatol
FT-0663911
GTPL7137
HE003351
HE045910
HE301769
HE303777
HE311426
HSDB 3018
HY-U00167
Insolat
Intasedol
Loubarb
LS-23930
LS-23946
LS-24330
LS-24334
Mebutal
Medarsed
Nerauan
Neravan
Nilox
Noctinal
NSC 11778
NSC 27517
NSC-11778
NSC-27517
NSC11778
NSC27517
Paxital (VAN)
Prelital
Pyridium plus (Salt/Mix)
Quiebar
Sarisol
Sarisol No. 1
SARISOL NO. 2
SCHEMBL122121
SCHEMBL79254
sec-Butobarbitone
Secbubarbital
Secbubarbital sodium
Secbutabarbital
Secbutabarbital (BAN)
Secbutabarbital [INN:BAN]
Secbutabarbital [INN]
Secbutabarbital sodique
Secbutabarbital sodium
Secbutabarbital sodium (INN)
Secbutabarbitale
Secbutabarbitale [DCIT]
Secbutabarbitalum
Secbutabarbitalum [INN-Latin]
Secbutobarbital
Secbutobarbitone
Secbutobarbitone sodium
Seda-Bute
Sodium 5-(sec-butyl)-5-ethylbarbiturate
SODIUM 5-ETHYL-2,4,6-TRIOXO-5-(SEC-BUTYL)-1,3-DIAZINAN-1-IDE
Sodium 5-ethyl-5-(1-methylpropyl)barbiturate
Sodium 5-ethyl-5-sec-butylbarbiturate
Sodium 5-sec-butyl-5-ethylbarbiturate
Sodium butabarbital
Sodium butobarbitone
Unicelles
WLN: T6VMVMV FHJ FY2 & 1 F2
ZRIHAIZYIMGOAB-UHFFFAOYSA-N

US Patents and Regulatory Information for BUTICAPS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-004 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Medpointe Pharm Hlc BUTICAPS butabarbital sodium CAPSULE;ORAL 085381-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
QuintilesIMS
Citi
Boehringer Ingelheim
McKesson
Cantor Fitzgerald
Healthtrust
Daiichi Sankyo
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.